Department of Biostatistics

Data haul improves immunotherapy response prediction

Vanderbilt biostatisticians have developed an immunotherapy response model that outperforms existing predictive models.

How to get the biggest “bang” for the research “buck”

Vanderbilt researchers are developing new methods to maximize what can be learned from clinical trials and cohort studies, while maintaining their rigor and reproducibility.

Blood clot simulation

Grant to advance prevention of hospital-acquired blood clots

A Vanderbilt team team will develop and test new clinical decision support tools to facilitate timely prevention of potentially lethal hospital-acquired blood clots, also known as venous thromboembolism.

Dandan Liu to lead the Association of Clinical and Translational Statisticians

Vanderbilt’s Dandan Liu, PhD, has been elected president of the Association of Clinical and Translational Statisticians.

Bryan Shepherd’s research to validate EHR data receives MERIT Award from the NIH

Vanderbilt’s Bryan Shepherd, PhDhas received a MERIT Award, or Method to Extend Research in Time Award, from the National Institute of Allergy and Infectious Diseases.

AI predicts blood clot risk in hospitalized children: VUMC study

An artificial intelligence tool developed at Vanderbilt accurately identified pediatric patients at high risk for blood clots in a clinical trial, with no difference in outcomes compared to a control group.

1 2 3 4